MorphoSys cans US R&D to consolidate work in Germany, taking $254M charge
MorphoSys cans US R&D to consolidate work in Germany, taking [...]
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot ‘expeditiously’
Selecta back in phase 1 gene therapy saddle after clinical [...]
Moderna doses 2nd arm of phase 2 booster study combining Spikevax with omicron-busting shot
Moderna doses 2nd arm of phase 2 booster study combining [...]
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease [...]
Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player
Morningside rolls up a pair of biotechs to birth clinical-phase [...]
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Venatorx hits goal in antibiotic phase 3, clearing path to [...]
Twist’s antibodies to wind up with Kriya’s AAV gene therapies in new pact
Twist’s antibodies to wind up with Kriya’s AAV gene therapies [...]
BeiGene’s hematology CMO jumps to steer pipeline changes at Prelude
BeiGene’s hematology CMO jumps to steer pipeline changes at Prelude [...]
J&J’s long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact
J&J’s long-acting injectable push barrels forward as it adds 2nd [...]
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayo
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines [...]